Most cancer treatments target different phases of the cell cycle.
However, without the tools to characterize cell cycle dysfunction at the individual patient level, many cancer treatments fall short in providing truly personalized care.
The QPOR™ Platform was created to directly measure and quantify cell cycle deregulations and tumor microenvironment dynamics to precisely predict a patient’s response to therapy.
Devised to measure and quantify cell cycle deregulations and tumor microenvironment dynamics, unlocking valuable insights into the collective tumor state.
The QPOR™ Platform aims to deliver insights that may help researchers and clinicians understand which treatment most effectively targets the cell cycle deregulations found in a patient’s tumor.
The QPOR™ Platform demonstrated improved therapeutic response prediction in multiple tumor types, across different therapeutic classes, and in both clinical trial and real-world settings.